Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 394 of 6351
-
Can a targeted nerve block spare children from opioids after chest surgery?
Symptom relief Recruiting nowThe goal of this clinical trial is to determine which regional block provides superior analgesia in pediatric patients undergoing thoracic surgery. The main questions it aims to answer are: * Does one block technique provide better pain relief? * Does the choice of block reduce …
Phase 2/3 • Sponsor: Children's Cancer Hospital Egypt 57357 • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can exercise rebuild lungs damaged by dust?
Disease control Recruiting nowThe goal of this randomized clinical trial is to compare the effects of aerobic exercise training and resistance exercise training on ventilatory function in quarry workers. It will also evaluate their effects on functional capacity and health-related quality of life (HRQOL). Th…
Sponsor: Cairo University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New drug aims to wipe out hidden leukemia cells
Disease control Recruiting nowThe purpose of this study is to assess the therapeutic efficacy of mosunetuzumab, a bispecific antibody targeting CD20 and CD3 in patients who have detectable chronic lymphocytic leukemia (CLL) after receiving Bruton's tyrosine kinase inhibitors (BTKis) for at least 6 months and …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New hope for tough lung cancer: combo therapy enters phase II trial
Disease control Recruiting nowThis Phase II study is a clinical study exploring the efficacy and safety of BL-M14D1 in combination with Atezolizumab in patients with extensive-stage small cell lung cancer.
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New TB cocktail aims to shorten treatment
Disease control Recruiting nowThe goal of this interventional trial is to evaluate the safety and efficacy of the loading dose regimen 200/100SPaL-4/13 weeks, and the 100SPaL -17 weeks regimen in adults with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis. Participants (18-65 years) wi…
Phase 2 • Sponsor: Global Alliance for TB Drug Development • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could CAR t cells tame vasculitis? early trial aims to find out
Disease control Recruiting nowThe purpose of this study is to evaluate the safety of CC-97540 in relapsed or refractory severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
Phase 1/2 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Stem cell 'secretome' may reboot the brain after stroke — a trial puts it to the test
Disease control Recruiting nowPost-stroke cognitive impairment can limit rehabilitation, independence, and quality of life after ischemic stroke. This pilot randomized controlled trial evaluates whether mesenchymal stem cell-derived secretome, given in addition to standard stroke care and rehabilitation, impr…
Sponsor: Jumraini Tammasse • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Engineered immune cells take aim at stubborn blood disorder
Disease control Not yet recruitingA Study of Metabolically Armed Autologous CD19 CAR T-Cell Therapy (META 10-19) in Patients with Relapsed/Refractory Autoimmune Hemolytic Anemia
Early phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a dual energy catheter tame dangerous heart rhythms?
Disease control Recruiting nowThe purpose of this study is to collect information about how safe Dual Energy THERMOCOOL SMARTTOUCH™ SF (DE STSF) catheter with TRUPULSE™ Generator is and how effective a specific procedural workflow is when this ablation system is used to treat ventricular arrhythmias. The main…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a diaphragm pacemaker help failing hearts?
Disease control Recruiting nowRECOVER HF is a clinical study designed to evaluate the safety and efficacy of Synchronized Diaphragmatic Stimulation delivered using the VisONE System in the treatment of patients with heart failure.
Sponsor: VisCardia Inc. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New hope for tough lymphoma: antibody combo targets cancer after CAR t fails
Disease control Recruiting nowThis phase II trial tests the safety and side effects of glofitamab and obinutuzumab and how well they work in treating patients with mantle cell lymphoma that has come back after a period of improvement (relapsed) or that has not responded to previous treatment (refractory) afte…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
New trial aims to stop oral lesions from turning into cancer
Disease control Recruiting nowThe goal of this clinical trial is to optimize treatment strategies for patients with p53-mutant oral epithelial dysplasia (OED) and early-stage oral squamous cell carcinoma (OSCC). The main question it aims to answer is what the most optimal treatment is at each diagnostic stage…
Sponsor: University of British Columbia • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New diabetes pill elecoglipron faces final test in 600-Patient trial
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with placebo in adults with Type 2 Diabetes Mellitus (T2DM), treated with a background insulin and other background glucose-lowering medication(s)
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can targeted supplements ease migraine suffering? new trial investigates
Disease control Not yet recruitingThe purpose of this study is to evaluate the impact of the Migraceutics® phase-specific dietary supplement regimen on quality of life, work productivity, and biomarkers in adult migraineurs.
Sponsor: Miracle Wellness LLC • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Suction device may improve outcomes in heart attack patients with large clots
Disease control Recruiting nowThe CAPTURE AMI trial is an investigator-initiated, single-centre, two-arm, randomised controlled trial. Patients aged ≥ 18 years who present with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) will be enrolled after angiog…
Phase 2/3 • Sponsor: Oxford University Hospitals NHS Trust • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Eye scans could spot deadly heart disease before symptoms appear
Diagnosis Recruiting nowThis multicenter pilot study will enroll adult participants with a confirmed clinical diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) and heart failure (HF) controls with documentation within the past 2 years that either excludes ATTR-CM or indicates a low probability…
Sponsor: AstraZeneca • Aim: Diagnosis
Last updated Aug 28, 2026 00:00 UTC
-
Can 4D-MRI spot brain aneurysms before they rupture?
Knowledge-focused Recruiting nowAn intracranial aneurysm is defined as a localized dilatation of the cerebral arteries, which can potentially lead to rupture and subsequent hemorrhagic stroke. The mechanisms by which aneurysms develop and grow remain unknown. The objective of this project is to utilize MRI, a r…
Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
New triple therapy aims to slow advanced lung cancer
Disease control Recruiting nowThis is a single center, phase Ib/II study combining an anti-PD-1 antibody and an anti-CTLA-4 antibody with IL-15. It is testing the hypothesis that the addition of nogapendekin alfa inbakicept to nivolumab and ipilimumab will augment the clinical activity of those two drugs.
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a scent of lavender and orange calm nerves before surgery?
Symptom relief Recruiting nowAromatherapy's Impact on Preoperative Anxiety, Postoperative Pain, and Patient Experience Introduction: Surgery often results in increased levels of anxiety and postoperative pain. Postoperative pain relief is typically treated with opioids. However, evidence shows that treatme…
Sponsor: Kaiser Permanente • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
One-Time brain injection targets genetic form of Parkinson's
Disease control Not yet recruitingThis is a prospective, single-arm, single-dose clinical study designed to evaluate the safety, tolerability, efficacy, immunogenicity, pharmacodynamic (PD) and pharmacokinetic (PK) profiles of LY-N001 Injection in patients with moderate-to-advanced Parkinson's disease carrying GB…
Early phase 1 • Sponsor: Lingyi Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC